Quantcast

Latest Treatment of ulcerative colitis Stories

2010-06-15 14:16:25

Discovery may lead to a new treatment McMaster University researchers have identified a specific chemical that may trigger remission in patients with the debilitating disease of ulcerative colitis. The team from the Farncombe Family Digestive Health Research Institute has found that people in long-term remission of ulcerative colitis have elevated levels of the same chemical, prostaglandin D2, which they previously found to be important in promoting healing and maintaining remission of the...

2010-05-03 07:25:53

Eating more olive oil could help prevent ulcerative colitis, according to a new study coordinated by medical researchers at the University of East Anglia (UEA). Presented May 1st at the Digestive Disease Week conference in New Orleans, the findings show that people with a diet rich in oleic acid "“ which is present in olive oil "“are far less likely to develop ulcerative colitis. Oleic acid is a monounsaturated fatty acid found in olive oil, peanut oil and grapeseed oil, as well...

2010-04-19 10:16:21

Inflammatory bowel disease is a chronic recurrent disease, which mainly consists of ulcerative colitis and Crohn's disease, and whose causes are as yet unclear. Many clinical and research studies have indicated that intestinal flora dysbacteriosis contributes to the pathogenesis of ulcerative colitis. Probiotics are non-pathogenic beneficial flora, which have important effects on maintaining the balance of intestinal flora. Many studies have discussed the positive effects of probiotics for...

2010-03-18 14:25:30

Research led by St. Jude Children's Research Hospital investigators identifies potential new targets for treatment of colitis and other inflammatory bowel diseases Scientists report a protein made by a gene already associated with a handful of human inflammatory immune diseases plays a pivotal role in protecting the intestinal tract from colitis. St. Jude Children's Research Hospital investigators led the research, which points to possible new strategies for combating colitis. Colitis is a...

2010-03-17 15:57:23

Greater understanding of genetics of ulcerative colitis key to developing new treatments, researchers say LOS ANGELES -- A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease. The study, published in Nature Genetics, examined genes of nearly 13,000 patients to determine which parts of the genome are linked to ulcerative...

2009-09-29 08:00:00

WALTHAM, Mass., Sept. 29 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to sales of Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe Pharma's Remicade, the two emerging TNF-alpha inhibitors Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe Pharma/Janssen's Simponi will drive sales of the TNF-alpha inhibitor drug class to nearly triple by...

2009-05-18 08:00:00

Free Medication Provided by Shire to Patients Taking Lialda(R) (mesalamine) or Pentasa(R) (mesalamine) for the Treatment of Ulcerative Colitis Who Have Lost Their Jobs in 2009 PHILADELPHIA, May 18 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, is responding to the needs of patients who are diagnosed with ulcerative colitis (UC) and prescribed gastrointestinal (GI) medications from Shire by expanding its Patient Assistant Program...

2009-01-19 11:17:54

Researchers from the Department of Biochemistry and Molecular Biology at the Univesidad de Alcalá (UAH), confirm that N-acetyl-L-cysteine (NAC) combined with mesalamine produces a significant improvement in patients suffering from ulcerative colitis. The team headed by Luis González Guijarro, biochemistry and molecular biology professor at the UAH, in collaboration with the pharmaceutical firm Farmasierra S.L., has developed a pilot study of the effects of N-acetyl-L-cysteine on...

2009-01-09 08:49:02

An international consortium of researchers, including major contribution from a team led by Dr. John D. Rioux, a professor of medicine at the Universit© de Montr©al and the Montreal Heart Institute, has identified genetic markers associated with risk for ulcerative colitis. The findings, published in the advance online journal Nature Genetics, bring researchers closer to understanding the biological pathways involved in the disease and may lead to the development of new treatments...

2008-10-07 09:00:14

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that 1.5 g mesalamine granules once-daily maintained remission versus placebo in ulcerative colitis (UC) patients who switched from another 5-ASA product (78 percent of relapse-free subjects vs. 59 percent (P less than 0.001)). These patients also had a greater probability of remaining relapse free after six months compared to placebo (77 percent vs. 50 percent (Pless than0.001) cumulative relapse-free probability)(1). Mesalamine...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related